BackCitius Oncology Overview

Citius Oncology Receivables

Track Citius Oncology's receivables ($690K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$686235.00

Peer trimmed avg / median

Loading

Citius Oncology Receivables History

Loading

Citius Oncology vs. peers: Receivables Comparison

Loading

Citius Oncology Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Citius Oncology (CTOR) FAQ

Citius Oncology (CTOR) currently reports a receivables of $690K as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Citius Oncology's receivables history and peer comparisons.

Citius Oncology's receivables changed from $0 to $690K (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Citius Oncology reported $690K in receivables as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $690K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Citius Oncology, and consider following CTOR for alerts when major investors trade the stock.